Willingdon Wealth Management’s Gilead Sciences GILD Stock Holding History

Willingdon Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-300	Closed	-$19K	–	367
2018 Q4	$19K	Hold	300	–	–	0.01%	239
2018 Q3	$23K	Hold	300	–	–	0.01%	254
2018 Q2	$21K	Hold	300	–	–	0.01%	234
2018 Q1	$23K	Buy	+300	New	+$23.8K	0.01%	213
2016 Q3	–	Sell	-10,917	Closed	-$911K	–	119
2016 Q2	$911K	Buy	10,917 +1,389	+15%	+$123K	0.47%	81
2016 Q1	$876K	Sell	9,528 -3,423	-26%	-$309K	0.54%	68
2015 Q4	$1.31M	Sell	12,951 -6,522	-33%	-$679K	1.2%	43
2015 Q3	$1.91M	Sell	19,473 -166	-0.8%	-$18.4K	2.27%	10
2015 Q2	$2.3M	Sell	19,639 -2,255	-10%	-$246K	2.2%	7
2015 Q1	$2.15M	Sell	21,894 -19,426	-47%	-$1.97M	1.78%	15
2014 Q4	$3.9M	Sell	41,320 -223	-0.5%	-$23.1K	2.45%	8
2014 Q3	$4.42M	Buy	41,543 +413	+1%	+$40.4K	2.91%	2
2014 Q2	$3.41M	Buy	41,130 +11,066	+37%	+$861K	2.36%	7
2014 Q1	$2.13M	Sell	30,064 -59	-0.2%	-$4.63K	1.5%	29
2013 Q4	$2.26M	Buy	+30,123	New	+$2.1M	1.78%	19

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Willingdon Wealth Management's GILD Position: Q1 2019 in Review

Willingdon Wealth Management sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 300 shares — an estimated $19K sold.

Willingdon Wealth Management first reported a position in GILD in Q4 2013 and held it in 15 quarters. The position peaked at $4.42M in Q3 2014. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

Willingdon Wealth Management reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
Willingdon Wealth Management sold 300 Gilead Sciences shares in Q1 2019, an estimated $19K.
Willingdon Wealth Management first reported a position in Gilead Sciences in Q4 2013 and held it in 15 quarters.
Willingdon Wealth Management's Gilead Sciences position peaked at $4.42M in Q3 2014.
1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Willingdon Wealth Management's 13F filing for Q1 2019, filed 9 May 2019.